Breakthrough for pig kidney transplants: Researchers know why body rejects it
SMRTR summary
Researchers at institutes in Paris and New York have made a breakthrough in pig-to-human kidney transplantation by mapping the human immune response at a molecular level. This led to successful interventions reducing rejection rates, paving the way for improved anti-rejection strategies. The advancement comes as the first US clinical trials of pig kidney transplants in humans are set to begin in 2025, potentially addressing the shortage of organ donors for the over 103,000 people on the US transplant waiting list.
SMRTR provides this summary for quick context. The original article belongs to Interesting Engineering.
Read the original article